Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
4(27%)
Results Posted
17%(1 trials)

Phase Distribution

Ph not_applicable
2
13%
Ph phase_1
2
13%

Phase Distribution

2

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
2(50.0%)
N/ANon-phased studies
2(50.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

4

trials recruiting

Total Trials

15

all time

Status Distribution
Active(4)
Completed(6)
Other(5)

Detailed Status

Completed6
unknown5
Recruiting4

Development Timeline

Analytics

Development Status

Total Trials
15
Active
4
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 12 (50.0%)
N/A2 (50.0%)

Trials by Status

unknown533%
recruiting427%
completed640%

Recent Activity

Clinical Trials (15)

Drug Details

Intervention Type
PROCEDURE
Total Trials
15